Home
Conditions
Diabetes Mellitus, Type 2

Clinical trial condition

Diabetes Mellitus, Type 2

Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.

8,020 public trials 711 recruiting studies

Refine in advanced search Browse all conditions

Diabetes Mellitus, Type 2 trial results

Completed

Efficacy and Long-Term Safety of Vildagliptin as Add-on Therapy to Metformin in Patients With Type 2 Diabetes

NCT00860288

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations: Instituto de Investigaciones Biomedicas Buenos Aires, Santa Fe Province, Argentina

Grupo Colaborative Rosario Rosario, Santa Fe Province, Argentina

Grupo Medico Alem Buenos Aires, Argentina

DIM Clinical Privada Buenos Aires, Argentina

View all 187 locations

View Trial Details

Completed

Diabetic Artery Obstruction: is it Possible to Reduce Ischemic Events With Cilostazol?

NCT02983214

Conditions: Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +17 more
Locations: Atherothrombosis Research Centre / Laboratory of Biochemistry, University of Ioannina Ioannina, Epirus, Greece

View Trial Details

Completed

Dietary Protein and Insulin Sensitivity Study

NCT00508937

Conditions: Cardiovascular Disease, Cardiovascular Diseases, Diabetes Mellitus, +12 more
Locations: Cholesterol Research Center Berkeley, California, United States

San Francisco General Hospital San Francisco, California, United States

View Trial Details

Completed

Effect of HBM Based Education on Glycemic Control of Type 2 Diabates Patients

NCT04677127

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations: Hacettepe University Ankara, Turkey (Türkiye)

View Trial Details

Completed

Efficacy and Safety of Fixed Combination Therapy of Vildagliptin and Metformin (25/1000 mg Bid) in Patients With Type 2 Diabetes Inadequately Controlled With Prior Metformin Monotherapy (HbA1c 7.0-9.5%)

NCT00728351

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations: Pine Bluff, Arkansas, United States

Long Beach, California, United States

Denver, Colorado, United States

Bangor, Maine, United States

View all 63 locations

View Trial Details

Completed

Efficacy of Fixed Combination Therapy of Vildagliptin and Metformin Compared to the Individual Monotherapy Components in Drug Naive Patients With Type 2 Diabetes

NCT00382096

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations: Novartis Pharmaceuticals East Hanover, New Jersey, United States

Multiple Locations, Germany

View Trial Details

Completed

A Sub-study to LMF237A2302 to Assess the Effect of 24 Weeks Treatment With Initial Combination of Vildagliptin Plus Metformin

NCT00468039

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations: Diabetes and Glandular Disease Research Associates San Antonio, Texas, United States

View Trial Details

Completed

Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) Assessment of LIK066 in Healthy Subjects and in Patients With Type 2 Diabetes Mellitus (T2DM)

NCT01407003

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations: Novartis Investigative Site Miami, Florida, United States

View Trial Details

Completed

Drug Interaction of Vildagliptin (LAF237) With Voglibose in Japanese Patients With Type 2 Diabetes

NCT01309698

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations: Novartis Investigative Site Tokyo, Japan

View Trial Details

Completed

DPP4 Inhibitor on Glycemic Variability

NCT04654676

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations: Sarawak General Hospital Kuching, Malaysia

View Trial Details

Diabetes Mellitus, Type 2

Diabetes Mellitus, Type 2 trial results

Related conditions